Clinical Guest Contributors

  1. Clinical Trial Standards — What They Are And Why They're Indispensable 9/8/2026

    Clinical trial standards are essential. But to interpret changes, preserve meaning, and assess downstream impact, context is key.

  2. Last-Mile Lessons For Depot-To-Site Delivery 9/7/2026

    Depot-to-site delivery is more than a courier handoff. See how reconciliation gaps, temperature risks, and mismatched SLAs can turn last-mile issues into trial delays.

  3. 5 Ways To Enrich The Clinical Trial Ecosystem 9/4/2026

    Sponsors must treat sites, PIs, and patients as connected parts of a living clinical trial ecosystem. Here are five ways to help make that happen.

  4. Turn AI Visibility Into Action: Build Explanation Layers For Different Stakeholders 9/4/2026

    AI visibility isn’t just about being found. Ross Jackson coaches sponsors on how to influence AI to provide clear stakeholder pathways for clinical trial involvement.

  5. Your Trial Shows Up In AI. Now What? 9/3/2026

    AI can explain your trial — but can it help patients act? Ross Jackson shares how sponsors can turn visibility into trust and next steps.

  6. The Promise Of MRD-Guided CAR-T Treatment 9/3/2026

    Minimal residual disease markers can reveal relapse before clinical signs appear, when off-the-shelf cell therapy may have its greatest advantage.

  7. Dose Escalation, Combination Strategy Keep Aprea Ahead In Its Oncology Trials 9/2/2026

    Aprea’s Gene Kennedy explains how smart dose escalation, next-gen sequencing, and combination planning are helping the company advance its oncology trial for multiple solid tumor types.

  8. How A $96M Gift Is Transforming Pediatric Brain Cancer Clinical Trial Infrastructure 9/1/2026

    By pairing donor priorities with research needs at Children's National, Milken Institute SPARC is turning philanthropy into faster trials, stronger infrastructure, and long-term care goals.

  9. Lessons In Forecasting Discipline From A $40B Supply Chain 8/31/2026

    Forecasting errors rarely start with the algorithm. They start when protocol changes, enrollment and site data reach the supply plan too late to prevent waste and disruption.

  10. The Pharmacy Benefit No One Is Managing: Clinical Research As A Care Option 8/28/2026

    Pharmacies could make trials more accessible — if they preserve patient trust while research partners handle the operational burden.